return to news
  1. M&M, Senco Gold, Zen Technologies, Glenmark Pharma, Godfrey Philips: Check top buzzing stocks of the day

Market News

M&M, Senco Gold, Zen Technologies, Glenmark Pharma, Godfrey Philips: Check top buzzing stocks of the day

Ahana Chatterjee - image.jpg

5 min read | Updated on February 17, 2025, 12:13 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Shares of Senco Gold on Monday hit their 52-week low as the company failed to impress investors with its December quarter earnings

Shares of Glaxo Pharma soared nearly 20% on Monday as the company’s net profit increased over five-fold during the December quarter. Image: Shutterstock

Shares of Glaxo Pharma soared nearly 20% on Monday as the company’s net profit increased over five-fold during the December quarter. Image: Shutterstock

Benchmark indices traded lower on Monday. The SENSEX dropped 366 points to 75,573, while the NIFTY50 declined 0.5% to 22,814. Mahindra & Mahindra, Mero MotoCorp, ICICI Bank, Bharat Electronics, and Tata Steel are the top laggards.

Here is a list of stocks that are buzzing in today's trade.
M&M: Shares of Mahindra & Mahindra (M&M), the auto major, slipped as much as 4.84% to ₹2,955 apiece on Monday, February 17, as the company on Friday said it has secured 30,179 bookings for its two new electric models—XEV 9e and BE 6.

The Mumbai-based auto major claimed the booking number translates to a value of ₹8,472 crore (at ex-showroom price). The company commenced bookings for the complete lineup of XEV 9e and BE 6 on Friday.

"Mahindra Electric Origin SUVs create a new record in the EV category by clocking 30,179 bookings on Day 1 with a booking value of ₹8,472 crore (at ex-showroom price)," Mahindra Group Chairman Anand Mahindra said in a tweet.

RVNL: Shares of Rail Vikas Nigam Limited (RVNL) tanked over 4.5% as the company reported subdued December quarter earnings.

During the early trade, RVNL was trading down 4.72% on BSE at ₹343 apiece.

RVNL on Saturday had reported 13.14% decline in consolidated net profit to ₹311.44 crore in October-December quarter as against ₹358.57 crore posted in Q3FY24.

Its revenue from operations also decreased 2.6% year-on-year (YoY) to ₹4,567.38 crore during the reporting quarter.

Zen Technologies: Shares of Zen Technologies hit a 20% lower circuit after the company reported a 22% jump in Q3FY25 profits. In addition, the company also announced the acquisition of ARIPL and ARI Labs.
In Q3FY25, total revenue jumped 44% YoY to ₹141 crore, compared to ₹98 crore in the previous year's similar quarter. The total order book as of Q3FY25 stood at ₹816 crore, out of which the company has executed orders worth ₹140 crore, with no new order win. The company’s standalone EBITDA increased by 21% YoY to ₹58.6 crore as compared ₹48 crore in the previous year's similar quarter. The net profit for the quarter jumped 22% YoY to ₹38.6 crore. Read more
Senco Gold: Shares of Senco Gold on Monday hit their 52-week low as the company failed to impress investors with its December quarter earnings.

At 10:55 AM, shares of Senco Gold were trading at ₹330.8 apiece, tanking 7.49% on BSE. The shares had touched its 52-week low of ₹304.5 during the intraday trade. The company is trading below its listing price of ₹431.

Senco Gold on Friday reported almost 70% loss in its profit for the October-December quarter for the current fiscal. Its share had declined nearly 20% on Friday after the earnings. The jewellery chain’s consolidated net profit for the December quarter declined 69.4% to ₹33.4 crore as compared to ₹109.3 crore in the corresponding quarter of the previous fiscal year. Read more
Bajaj Finserv: Shares of Bajaj Finserv rose over 2% on Monday as various analysts revised their outlook for the company.

During the intraday trade, shares of the company was trading at ₹1,879.6 apiece, rising 2.13% on BSE.

Glenmark Pharma: Shares of Glenmark Pharmaceuticals advanced almost 4% on Monday, February 17, after the company reported strong December quarter earnings aided by good performance across segments.

At 10:25 AM, the company was trading at ₹1,373 apiece on BSE, soaring 3.91%.

The pharma major on Friday said its consolidated profit after tax stood at ₹348 crore for the third quarter ended December 31 as compared to a net loss of ₹351 crore in the corresponding quarter of the previous fiscal. Consolidated revenue stood at ₹3,388 crore in the third quarter as against ₹2,507 crore in the year-ago period, the Mumbai-based company said in a statement. Read more
Glaxosmithkline Pharmaceuticals: Shares of the drug firm soared nearly 20% on Monday as the company’s net profit increased over five-fold during the December quarter.

Glaxo Pharma’s net profit increased rose to ₹229 crore for the third quarter ended December 31, 2024. The drug firm reported a net profit of ₹45 crore for the October-December quarter of last fiscal.

Revenue from operations rose to ₹949 crore for the third quarter, as compared to ₹805 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a statement.

During the intraday trade, shares of the company was trading at ₹2,405 apiece on BSE, surging 19.19%.

Godfrey Philips: Amid the ruthless sell-off in the domestic market across almost all the sectors and market capitalisations, one of the stocks that have stood tall and given impressive returns is Godfrey Phillips India.

The stock has jumped nearly 53% in the past one month, per BSE data. In comparison, the benchmark S&P BSE SENSEX has fallen over 1%. The BSE FMCG index during the period has slipped 5.75%, the data show.

Godfrey Phillips India, a flagship company of Modi Enterprises—KK Modi Group, is one of the largest FMCG companies in India. The stock is part of the BSE500 universe. The company is known for its cigarette brands such as Four Square, Red & White, Cavanders, Stellar, Focus, Originals International, and others.

At the time of writing this article, Godfrey Phillips India shares were trading 18.69% higher at ₹7,097.10 apiece on the BSE. Read more
Northern Arc: NBFC Northern Arc Capital on Friday reported an almost flat consolidated net profit at ₹76 crore in the third quarter ended December 2024.

The lender had earned a net profit of ₹75 crore in the same quarter a year ago.

The total income on a consolidated basis increased to ₹581 crore during the quarter under review against ₹497 crore in the same quarter last year, Northern Arc Capital Ltd said in a regulatory filing.

During the intraday trade, the company was trading 2.96% lower on BSE at ₹168.85 apiece. Northern Arc also touched its 52-week low of ₹165.9 during the day.

Upstox

About The Author

Ahana Chatterjee - image.jpg
Ahana Chatterjee is a business journalist with 7 years of experience across several leading news platforms. At Upstox, she covers stock markets and corporate news.

Next Story